Table 4.
Models | Discrimination | ||||
---|---|---|---|---|---|
Harrell's C Index | Net Reclassification Improvement | P Value | Integrated Discrimination Improvement | P Value | |
Established risk factors | 0.820 | Reference | Reference | ||
Established risk factors + Hb | 0.824 | 0.167 | 0.158 | 0.0080 | 0.200 |
Established risk factors + RDW | 0.830 | 0.321 | 0.007 | 0.0126 | 0.045 |
Established risk factors + Hb + RDW | 0.831 | 0.297 | 0.012 | 0.0143 | 0.042 |
Abbreviations: Hb, hemoglobin; RDW, red cell distribution width. The net reclassification improvement was defined as (Pimproved_prediction_among_patients with MACE + Pimproved_prediction_among_patients without MACE) − (Pworsened_prediction_among_patients with MACE + Pworsened_prediction_among_patients without MACE), where P = proportion of patients. The integrated discrimination improvement was defined as (Σi MACE (Pnew(i) ‐ Pold(i))/n [patients with MACE]) ‐ (Σj non‐MACE (Pnew(j) ‐Pold(j))/n [patients without MACE]), where P = predicted probability of major adverse cardiac events. Established risk factors defined as sex, age >65 years, body mass index, prior coronary heart disease, hypertension, diabetes mellitus, serum creatinine, total cholesterol, percutaneous coronary intervention, antiplatelet agents, β‐blockers, and angiotensin‐converting enzyme inhibitors/angiotensin II type 1 receptor blockers use.